Financial reports
10-K
2023 FY
Annual report
28 Feb 24
10-Q
2023 Q3
Quarterly report
30 Oct 23
10-Q
2023 Q2
Quarterly report
31 Jul 23
10-Q
2023 Q1
Quarterly report
1 May 23
10-K
2022 FY
Annual report
1 Mar 23
10-Q
2022 Q3
Quarterly report
9 Nov 22
10-Q
2022 Q2
Quarterly report
1 Aug 22
10-Q
2022 Q1
Quarterly report
5 May 22
10-K
2021 FY
Annual report
1 Mar 22
10-Q
2021 Q3
Quarterly report
4 Nov 21
Current reports
8-K
Other Events
4 Apr 24
8-K
Axonics Stockholders Approve Merger Agreement with Boston Scientific
25 Mar 24
8-K
Axonics Reports Fourth Quarter and Fiscal Year 2023 Financial Results
28 Feb 24
8-K
Entry into a Material Definitive Agreement
8 Jan 24
8-K
Axonics Reports Preliminary 4Q23 and Fiscal Year 2023 Revenue
8 Jan 24
8-K
Axonics Reports Third Quarter 2023 Financial Results
30 Oct 23
8-K
Departure of Directors or Certain Officers
4 Oct 23
8-K
Axonics Announces CFO Retirement and Appoints Successor
21 Aug 23
8-K
Axonics Reports Second Quarter 2023 Financial Results
27 Jul 23
8-K
Submission of Matters to a Vote of Security Holders
27 Jun 23
Registration and prospectus
424B5
Prospectus supplement for primary offering
18 May 23
S-3ASR
Automatic shelf registration
4 May 23
S-8
Registration of securities for employees
7 Mar 23
424B5
Prospectus supplement for primary offering
4 Aug 22
424B5
Prospectus supplement for primary offering
2 Aug 22
424B5
Prospectus supplement for primary offering
2 Aug 22
424B5
Prospectus supplement for primary offering
13 May 21
424B5
Prospectus supplement for primary offering
11 May 21
424B5
Prospectus supplement for primary offering
30 Apr 21
424B5
Prospectus supplement for primary offering
3 Mar 21
Proxies
DEFA14A
Additional proxy soliciting materials
7 Mar 24
DEFM14A
Proxy related to merger
22 Feb 24
DEF 14A
Definitive proxy
8 Jan 24
DEF 14A
Definitive proxy
1 May 23
DEFR14A
Revised proxy
13 May 22
DEF 14A
Definitive proxy
15 Apr 22
PRE 14A
Preliminary proxy
5 Apr 22
DEF 14A
Definitive proxy
30 Apr 21
DEFA14A
Additional proxy soliciting materials
22 Jun 20
DEF 14A
Definitive proxy
29 Apr 20
Other
UPLOAD
Letter from SEC
22 Nov 21
CORRESP
Correspondence with SEC
9 Nov 21
UPLOAD
Letter from SEC
26 Oct 21
EFFECT
Notice of effectiveness
19 Nov 19
CORRESP
Correspondence with SEC
15 Nov 19
UPLOAD
Letter from SEC
14 Nov 19
CORRESP
Correspondence with SEC
14 Nov 19
CT ORDER
Confidential treatment order
6 Nov 18
EFFECT
Notice of effectiveness
31 Oct 18
CERT
Certification of approval for exchange listing
29 Oct 18